Manouchehr Khoshbaten

Manouchehr Khoshbaten

Auto-generated profile, based on publicly available information

Manouchehr Khoshbaten

Liver and Gastrointestinal Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 July 2008 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Closed access
PDF file
MKManouchehr Khoshbaten
Manouchehr Khoshbaten
HKHomayoun Khorram
Homayoun Khorram
LMLeili Madad
Leili Madad
MAMohammad Javad Ehsani Ardakani
Mohammad Javad Ehsani Ardakani
HFHaleh Farzin
Haleh Farzin
MZMohammad Reza Zali
Mohammad Reza Zali

20 March 2017 in Journal of the American College of Nutrition
Verified
Journal Article
Closed access
RNRoya Navekar
Roya Navekar
MRMaryam Rafraf
Maryam Rafraf
AGAida Ghaffari
Aida Ghaffari
MAMohammad Asghari-Jafarabadi
Mohammad Asghari-Jafarabadi
MKManouchehr Khoshbaten
Manouchehr Khoshbaten
Insulin and leptin resistance are important risk factors for non-alcoholic fatty liver disease (NAFLD). There is limited evidence regarding the effects of turmeric on NAFLD. The aim of this study was to investigate the effects of turmeric supplementation on glycemic status and serum leptin levels in patients with NAFLD. This double-blind randomized controlled clinical trial was conducted on 46 patients with NAFLD (21males and 25 females) aged 20-60 years old and body mass index (BMI) between 24.9 and 40 kg/m2. The turmeric group (n = 23) was given six turmeric capsules daily for 12 weeks. Each capsule contained 500 mg turmeric powder (6×500 mg). The placebo group (n = 23) was given six placebo capsules daily for the same period. Fasting blood samples, anthropometric measurements, and physical activity levels were collected at the baseline and at the end of the study. Daily dietary intakes also were obtained throughout the study. Data were analyzed by independent t test, paired t test and analysis of covariance. Turmeric consumption decreased serum levels of glucose, insulin, HOMA-IR and leptin (by 1.22, 17.69, 19.48 and 21.33% respectively, p < 0.05 for all) over 12 weeks compared with those variables in the placebo group. Changes in weight, BMI and liver enzymes were not significant compared to the placebo group. Turmeric supplementation improved glucose indexes and serum leptin levels and may be useful in the control of NAFLD complications.

1 October 2014 in Archives of Medical Research
Verified
Journal Article
Closed access
MFMahdieh Abbasalizad Farhangi
Mahdieh Abbasalizad Farhangi
BABeytollah Alipour
Beytollah Alipour
EJElnaz Jafarvand
Elnaz Jafarvand
MKManouchehr Khoshbaten
Manouchehr Khoshbaten

17 May 2005 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
MTMahnaz Taremi
Mahnaz Taremi
MKManouchehr Khoshbaten
Manouchehr Khoshbaten
LGLatif Gachkar
Latif Gachkar
MEMohammadJavad EhsaniArdakani
MohammadJavad EhsaniArdakani
MZMohammad Reza Zali
Mohammad Reza Zali
Background: The hepatitis E virus (HEV) has a global distribution and is known to have caused large waterborne epidemics of icteric hepatitis. Transmission is generally via the fecal-oral route. Some reports have suggested parenteral transmission of HEV. Anti-HEV prevalence data among chronic hemodialysis (HD) patients are few and give conflicting results. Methods: This cross-sectional study was conducted in August of 2004. We tested 324 chronic HD patients attending three different units in the city of Tabriz, northwestern part of Iran, for anti-HEV antibody. A specific solid- phase enzyme-linked immunoassay (Diapro, Italy) was used. Results: The overall seroprevalence of hepatitis E was 7.4 %(95% CI: 4.6%–10.6%). The prevalence rate of HBV and HCV infection were 4.6% (95% CI: 2.3%–6.9%) and 20.4% (95% CI: 16%–24.8%), respectively. No significant association was found between anti-HEV positivity and age, sex, duration of hemodialysis, positivity for hepatitis B or C virus infection markers and history of transfusion. Conclusion: We observed high anti-HEV antibody prevalence; there was no association between HEV and blood borne infections (HBV, HCV, and HIV) in our HD patients. This is the first report concerning seroepidemiology of HEV infection in a large group of chronic HD individuals in Iran.

1 January 2006 in World Journal of Gastroenterology
Verified
Journal Article
Open access
AAAmir Houshang Mohammad Alizadeh
Amir Houshang Mohammad Alizadeh
SFSeyed Reza Fatemi
Seyed Reza Fatemi
VMVahid Mirzaee
Vahid Mirzaee
MKManoochehr Khoshbaten
Manoochehr Khoshbaten
BTBahman Talebipour
Bahman Talebipour
MZMohammad Reza Zali
Mohammad Reza Zali
Clinical features of hepatopulmonary syndrome in cirrhotic patients

1 January 2015 in Journal of Research in Medical Sciences
Verified
Journal Article
Open access
PDF file
MKManouchehr Khoshbaten
Manouchehr Khoshbaten
ASAlireza Shaygan-Nejad
Alireza Shaygan-Nejad
AMAbdol Rahim Masjedizadeh
Abdol Rahim Masjedizadeh
AGAli Ghavidel
Ali Ghavidel
MGMorteza Ghojazadeh
Morteza Ghojazadeh
Background: Pancreatitis is a serious complication of endoscopic retrograde cholangiopancreatography (ERCP) and may cause significant morbidity and even death. There is no effective prophylactic intervention for patients with average risk yet. This study aims to investigate preventive effect of aggressive hydration for post-ERCP pancreatitis. Materials and Methods: In a double-blind controlled setting, 150 patient were randomly assigned to receive either aggressive hydration with lactated Ringer's solution (3 mL/kg/h during ERCP, followed by a 20 mL/kg bolus and 3 mL/kg/h for 8 h after the procedure, n = 75) or standard amount of hydration (1.5 mL/kg/h during and for 8 h after ERCP, n = 75). Patients were observed for volume overload as well as pancreatic pain and serum levels of amylase at baseline and 2, 8, and 24 h after ERCP. Post-ERCP pancreatitis was defined as hyperamylasemia (level of amylase >300) and pancreatic pain during the 24 h follow-up. Hyperamylasemia and pancreatic pain were the secondary end points. Results: Mean age of the patients was 50.8 ± 13.5 years. Most of the patients were female (66%). Pancreatitis developed in 21 patients, including 22.7% of patients receiving standard hydration and 5.3% patients receiving aggressive hydration (P = 0.002). Hyperamylasemia was detected in 44.0% of patients receiving standard hydration and 22.7% of patients aggressive hydration (P = 0.006). The pancreatic pain was reported by 5.3% of patients receiving aggressive hydration and 37.3% of patients receiving standard hydration (P ≤ 0.005). Conclusion: Aggressive hydration with lactated Ringer's solution may effectively prevent post-ERCP pancreatitis as well as hyperamylasemia and pancreatic pain in patients with average risk.